The largest database of trusted experimental protocols

4 protocols using win55 212

1

Pharmacological Modulation of Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
WIN55,212 (WIN: in vitro: 0.5µM; in vivo: 3mg/kg), AM251 (10µM), ZD7288 (in vitro: 0.1mM; in vivo: 15µg/animal), SB203580 (p38-inhibitor; 10µM), SP600125 (JNK-inhibitor; 10µM), JZL184 (JZL; 1µM), URB597 (URB; 1µM), gallein (10µM), anisomycin (30µM), ODQ (10µM), L-NAME (100µM), DDOA (10mM) were obtained from Tocris (Ellisville, MO). CPTIO (1mM or 10mM) was obtained from Cayman (Ann. Arbor, MI).
+ Open protocol
+ Expand
2

Pharmacological Modulation of Pain Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
HU210, WIN55212 and STZ (streptozotocin) were purchased from Tocris Bioscience (Abingdon, UK). CFA (Complete Freund’s Adjuvant) was purchased from Sigma-Aldrich (Munich, Germany). Tramadol was purchased from The Arab Pharmaceutical Manufacturing Co. Ltd. (Amman, Jordan). Morphine was purchased from Hikma Pharmaceuticals LLC (Amman, Jordan). Unless otherwise indicated, drugs were initially dissolved in ethanol (100%) to form a stock solution, and then diluted in (3% tween 20 in saline).
+ Open protocol
+ Expand
3

Pharmacological Modulation of Neuroreceptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
(RS)-Baclofen (BAC), sumatriptan succinate, [D-Ala2, NMe-Phe4, Gly-ol5]-enkephalin (DAMGO), (-)–U50488, WIN 55-212, (1R, 4R, 5S, 6R)-4-Amino-2-oxabicyclo [3.1.0] hexane-4,6-dicarboxylic acid (LY379268), histamine dihydrochloride (HA), N6-Cyclopentyladenosine (CPA), all purchased from Tocris Bioscience. Picrotoxin (PTX) purchased from Sigma Aldrich. Benzyloxy-Cyclopentyladenosine (BnOCPA) was provided by the Hamm Lab.
+ Open protocol
+ Expand
4

Investigating CB1 Receptor Agonist Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CB1 receptor agonist, WIN [WIN 55212-2 mesylate (R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl) methyl]pyrrolol[1,2, 3 de]-1,4-benzoxazinyl]-(1-naphthalenyl) methanone)], was obtained from Tocris Biosciences (Bristol, UK) and dissolved in 50% of DMSO and 0.9% saline. Solutions were prepared at a concentration of 2 mg/ml and drug or vehicle was administered by intraperitoneal (i.p.) injection at a volume of 1 ml/kg. The drug was administered 20 min before seizure testing.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!